Concepedia

Publication | Closed Access

Phase II Clinical Experience With the Novel Proteasome Inhibitor Bortezomib in Patients With Indolent Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma

DOI

579

Citations

29

References

2004

Year

Owen A. O’Connor, Craig H. Moskowitz, Jamie Muzzy, Barbara MacGregor‐Cortelli, Michael D. Stubblefield, David J. Straus, Carol S. Portlock, Paul A. Hamlin, Elizabeth Choi, Otila Dumetrescu,
Journal of Clinical Oncology

Abstract

These data suggest that bortezomib was well tolerated and has significant single-agent activity in patients with certain subtypes of NHL.

References

YearCitations

Page 1